#Hindustan Syringes

[5545321]

Pen Needles Market to be Worth $12.88 Billion by 2031

 Meticulous Research®—a leading global market research company, published a research report titled ‘Pen Needles Market by Type (Standard, Safety), Needle Length, Usability (Disposable, Reuse), Application (Insulin, Growth Hormone, GLP-1), Distribution Channel (Hospital Pharmacy, Retail, Online), Setting (Home Care, Hospital) — Global Forecast to 2031.’

According to this latest publication from Meticulous Research®, the pen needles market is projected to reach $12.88 billion by 2031, at a CAGR of 9.9% during the forecast period. The growth of this market is driven by factors such as the rising prevalence of diabetes, growing demand for self-administration of drugs, advancements in technology, and rising healthcare expenditure. Moreover, the preference for pen needles over vials and syringes, favorable reimbursement policies, and emerging economies are expected to offer significant market growth opportunities.

However, concerns regarding needlestick injuries restrain the market’s growth. Additionally, the reuse of pen needles, limited access to healthcare in developing nations, and lack of awareness about proper usage of pen needles pose challenges to the market’s growth.

Key Players

The key players operating in the pen needles market are Becton, Dickinson and Company (U.S.), Novo Nordisk A/S (Denmark), Ypsomed AG (Switzerland), Owen Mumford Limited (U.K.), B. Braun Melsungen AG (Germany), Terumo Group (Japan), Allison Medical, Inc. (U.S.), Cardinal Health, Inc. (U.S.), UltiMed, Inc. (U.S.), Hindustan Syringes & Medical Devices Ltd (India), and Nanchang YiLi Medical Instrument Co.,LTD (China).

Pen Needles Market: Future Outlook

The pen needles market is segmented based on Type (Standard Pen Needles, Safety Pen Needles), Needle Length (4 mm, 5 mm, 6 mm, 8 mm, 10 mm, 12 mm & Above), Usability (Single Use/Disposable, Reusable), Application (Insulin Therapy, Growth Hormone Therapy, GLP-1 Therapy, Other Applications), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), Healthcare Setting (Home Care, Hospitals & Clinics, and Other Healthcare Settings), and Geography. The study also evaluates industry competitors and analyzes the regional and country-level markets.

Based on type, the pen needles market is segmented into standard pen needles and safety pen needles. In 2024, the safety pen needles segment is expected to account for the larger share of the pen needles market. The large market share of this segment can be attributed to the advantages provided by safety pen needles, including reduced risk of needlestick injuries, assured delivery of the full medication dose in a safe manner, and enhanced control during the injection process with clear visibility of the sterile needle. Additionally, the incorporation of safety shields in safety pen needles further contributes to the segment's significant market share.

Based on needle length, the pen needles market is segmented into 4 mm, 5 mm, 6 mm, 8 mm, 10 mm, 12 mm & above. In 2024, the 4 mm segment is expected to account for the largest share of the pen needles market. The large market share of this segment can be attributed to the advantages offered by 4 mm needles, such as minimal pain and discomfort during insulin injections. Furthermore, companies in the pen needles market are focusing on improving their product portfolios through the introduction of innovative offerings. For instance, in September 2022, Terumo Group (Japan) launched FineGlide, a sterile pen needle designed for patients requiring insulin injections or other forms of self-medication.

Based on usability, the pen needles market is segmented into single-use/disposable and reusable. In 2024, the single-use/disposable segment is expected to account for the larger share of the pen needles market. The large market share of this segment can be attributed to technological advancements in insulin delivery devices and growing awareness regarding hygiene and needlestick injuries.

Based on application, the pen needles market is segmented into insulin therapy, growth hormone therapy, GLP-1 therapy, and other applications. In 2024, the insulin therapy segment is expected to account for the largest share of the pen needles market. The large market share of this segment can be attributed to the rising demand and awareness of insulin therapy, driven by the high prevalence of diabetes. For instance, according to the International Diabetes Federation, the global diabetic population reached 537 million in 2021. Projections indicate an increase to 643 million by 2030 and 783 million by 2045.

Based on distribution channel, the pen needles market is segmented into hospital pharmacies, retail pharmacies, and online channels. In 2024, the retail pharmacies segment is expected to account for the largest share of the pen needles market. The large market share of this segment can be attributed to the advantages provided by retail pharmacies compared to other distribution channels. Retail pharmacies offer patients the convenience of accessing pen needles without the need for a prescription, thereby simplifying diabetes management for individuals.

Based on healthcare setting, the pen needles market is segmented into home care, hospitals and clinics, and other healthcare settings. In 2024, the home care segment is expected to account for the largest share of the pen needles market. The large market share of this segment can be attributed to the growing awareness of diabetes management and the rising number of diabetes cases. Additionally, the adoption of pen needles in home care settings enables individuals to manage their healthcare independently. By self-administering medications, individuals gain greater control over their treatment, seamlessly integrating it into their daily routines. This autonomy often leads to improved medication adherence and better overall health outcomes.

Geographic Review

This research report analyzes major geographies and provides a comprehensive analysis of North America (U.S. and Canada), Europe (Germany, France, U.K., Italy, Spain, Austria, Netherlands, and Rest of Europe), Asia-Pacific (China, Japan, India, South Africa, Australia, and Rest of Asia-Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and the Middle East & Africa. In 2023, North America is expected to account for the largest share of the pen needles market, followed by Europe and Asia-Pacific. Furthermore, in 2023, the U.S. is expected to be the largest market shareholder in North America. North America’s major market share is attributed to the highly developed healthcare infrastructure and the presence of major market players such as Becton, Dickinson and Company (U.S.), and Cardinal Health, Inc. (U.S.).

Download Sample Report Here @ https://www.meticulousresearch.com/download-sample-report/cp_id=5796

Key questions answered in the report:

· Which are the high-growth market segments in terms of type, needle length, usability, application, distribution channel, healthcare setting, and region/country?

· What was the historical market size for pen needles across the globe?

· What are the market forecasts and estimates for 2024–2031?

· What are the major drivers, restraints, and opportunities in the global pen needles market?

· Who are the major players in the global pen needles market?

· What is the competitive landscape like, and who are the market leaders in the global pen needles market?

· What are the recent developments in the pen needles market?

· What strategies are adopted by the major players in the pen needles market?

· What are the geographical trends and high-growth regions/countries?

Contact Us: Meticulous Research® Email- [email protected] Contact Sales- [phone] Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research

#Pen Needles Market

[medicaldevicesmarket]

Transforming Healthcare: A Comprehensive Overview of the Medical Devices Market

In the dynamic landscape of healthcare, the Medical Devices Market plays a pivotal role, shaping the diagnosis, treatment, and management of various medical conditions. This comprehensive overview delves into the current state of the global market, highlighting key drivers, market segmentation, challenges, opportunities, and the noteworthy presence of medical devices companies in India.

Global Medical Devices Market: A Snapshot

The global Medical Devices Market is a vast and diverse sector encompassing a wide array of products, from diagnostic equipment to implantable devices. Valued at USD 456.9 billion in 2023, the market is projected to reach USD 686.1 billion by 2030, reflecting a substantial CAGR of 5.8% during the forecast period. This growth is attributed to technological advancements, increasing healthcare expenditures, and a growing aging population.

Key Drivers of Market Growth:

Technological Advancements: Continuous innovations, such as the integration of IoT, artificial intelligence, and robotics, are driving the development of advanced and smart medical devices.

Rising Chronic Diseases: The surge in the prevalence of chronic diseases, including cardiovascular disorders and diabetes, is fueling the demand for sophisticated medical devices for effective diagnosis and treatment.

Global Aging Population: With a significant portion of the global population entering old age, there is a heightened need for medical devices catering to age-related health issues.

Market Segmentation:

The Medical Devices Industry is segmented based on product types, applications, and end-users:

Diagnostic and Imaging Devices

Surgical Devices

Patient Monitoring Devices

In-Vitro Diagnostic Devices

Dental Devices

Orthopedic Devices

Cardiovascular Devices

Ophthalmic Devices

Challenges and Opportunities:

Challenges:

Regulatory Compliance: Stringent regulatory requirements pose challenges for market players, demanding adherence to rigorous approval processes.

Cost Constraints: High manufacturing and development costs can limit accessibility, particularly in regions with constrained healthcare budgets.

Opportunities:

Emerging Markets: Untapped markets in developing countries present opportunities for market expansion, driven by increased healthcare investments and infrastructure development.

Digital Health Integration: The integration of digital health technologies into medical devices offers opportunities for enhanced connectivity, remote monitoring, and personalized patient care.

Medical Devices Companies in India: A Rising Presence

India is emerging as a significant player in the global medical devices market, with several indigenous companies making notable contributions. Prominent Indian medical devices companies include:

Siemens Healthineers India

Wipro GE Healthcare

Philips India

Trivitron Healthcare

Stryker India

Hindustan Syringes & Medical Devices Ltd. (HMD)

These companies are actively engaged in the development, manufacturing, and distribution of a wide range of medical devices, contributing to the growth and innovation within the sector.

Future Outlook:

The Medical Devices Market is poised for continued growth and transformation, driven by ongoing technological advancements, the demand for personalized healthcare solutions, and the global focus on improving patient outcomes. As healthcare ecosystems evolve, medical devices will play an increasingly crucial role in shaping the future of healthcare delivery worldwide.

#healthcare #medical devices #industry #business #market research

[tejalbele-2024]

Insulin Syringes Market to Reach $2.40 Bn, Globally, by 2030 at 4.4% CAGR: Allied Market Research

Allied Market Research recently published a report, titled, "Insulin Syringes Market by Syringe Size (3/10 cc Syringe (0.3ml), 1/ 2 cc Syringe (0.5ml), 1cc syringe (1ml), and Others), Disease (Type-1 Diabetes and Type-2 Diabetes), End User (Hospital & Clinics, Homecare Settings, and Others): Global Opportunity Analysis and Industry Forecast, 2021–2030". As per the report, the global insulin syringes industry was pegged at USD 1.56 billion in 2020, and is expected to reach USD 2.40 billion by 2030, growing at a CAGR of 4.4% from 2021 to 2030.

𝐅𝐨𝐫 𝐑𝐢𝐠𝐡𝐭 𝐏𝐞𝐫𝐬𝐩𝐞𝐜𝐭𝐢𝐯𝐞 𝐚𝐧𝐝 𝐂𝐨𝐦𝐩𝐞𝐭𝐢𝐭𝐢𝐯𝐞 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬, 𝐆𝐞𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 𝐚𝐭: https://www.alliedmarketresearch.com/request-sample/3740

𝐌𝐚𝐣𝐨𝐫 𝐝𝐞𝐭𝐞𝐫𝐦𝐢𝐧𝐚𝐧𝐭𝐬 𝐨𝐟 𝐭𝐡𝐞 𝐦𝐚𝐫𝐤𝐞𝐭 𝐠𝐫𝐨𝐰𝐭𝐡

Increase in prevalence of diabetes, surge in the geriatric population, and rise in healthcare expenditure have boosted the growth of the global insulin syringes market. However, high price of insulin and the availability of alternative modes of insulin delivery hinder the market growth. On the contrary, high growth potential in developing countries is expected to open new opportunities for the market players in the future.

𝐂𝐨𝐯𝐢𝐝-𝟏𝟗 𝐬𝐜𝐞𝐧𝐚𝐫𝐢𝐨:

The Covid-19 pandemic led to a lockdown and imposed social distancing measures across several countries. The lockdown disrupted the supply chain, production, and distribution. Patients with high blood pressure and diabetes are at higher risk of getting affected by the virus. Thus, the demand for insulin administration surged during the pandemic. The type-2 diabetes segment to manifest the highest CAGR through 2030

By disease, the type-2 diabetes segment is estimated to portray the highest CAGR of 4.9% during the forecast period. In addition, the segment held the largest share in 2020, accounting for nearly three-fifths of the market, owing to rise in case of type 2 diabetes across the world. The research also analyzes the type-1 diabetes segment.

𝐏𝐫𝐨𝐜𝐮𝐫𝐞 𝐂𝐨𝐦𝐩𝐥𝐞𝐭𝐞 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐑𝐞𝐩𝐨𝐫𝐭 𝐍𝐨𝐰 : https://www.alliedmarketresearch.com/insulin-syringes-market/purchase-options

𝐓𝐡𝐞 𝐜𝐥𝐢𝐧𝐢𝐜𝐬 𝐬𝐞𝐠𝐦𝐞𝐧𝐭 𝐝𝐨𝐦𝐢𝐧𝐚𝐭𝐞𝐝 𝐭𝐡𝐞 𝐦𝐚𝐫𝐤𝐞𝐭

By end user, the hospital & clinics segment held the largest share in 2020, contributing to nearly half of the market. In addition, the segment is projected to manifest the highest CAGR of 5.3% during the forecast period, owing to rise in prevalence of chronic diseases such as diabetes and increase in elderly population. The report also analyzes the segments including homecare and others.

𝐍𝐨𝐫𝐭𝐡 𝐀𝐦𝐞𝐫𝐢𝐜𝐚 𝐡𝐞𝐥𝐝 𝐭𝐡𝐞 𝐥𝐢𝐨𝐧'𝐬 𝐬𝐡𝐚𝐫𝐞

By region, the market across North America held the largest share in 2020, accounting for nearly two-fifths of the market. This is due to high expenditure on R&D, well-established healthcare infrastructure, and presence of major players & their product availability. However, the market across Asia-Pacific is expected to register the highest CAGR of 6.5% during the forecast period, owing to improvement in R&D facilities, rapidly developing economic conditions, and disposable income.

𝐃𝐨 𝐘𝐨𝐮 𝐇𝐚𝐯𝐞 𝐀𝐧𝐲 𝐐𝐮𝐞𝐫𝐲 𝐎𝐫 𝐒𝐩𝐞𝐜𝐢𝐟𝐢𝐜 𝐑𝐞𝐪𝐮𝐢𝐫𝐞𝐦𝐞𝐧𝐭? 𝐀𝐬𝐤 𝐭𝐨 𝐎𝐮𝐫 𝐈𝐧𝐝𝐮𝐬𝐭𝐫𝐲 𝐄𝐱𝐩𝐞𝐫𝐭: https://www.alliedmarketresearch.com/purchase-enquiry/3740

𝐌𝐚𝐣𝐨𝐫 𝐦𝐚𝐫𝐤𝐞𝐭 𝐩𝐥𝐚𝐲𝐞𝐫𝐬

▪️ Novo Nordisk A/S ▪️ Abbott Laboratories ▪️ Biocon Ltd. ▪️ Cardinal Health Inc. ▪️ Terumo Corporation ▪️ Eli Lilly and Company ▪️ Beckton and Dickinson Company ▪️ Nipro Medical Corporation ▪️ Medline Industries ▪️ Hindustan syringe and medical device Ltd.

𝐀𝐛𝐨𝐮𝐭 𝐔𝐬

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

𝐂𝐨𝐧𝐭𝐚𝐜𝐭:

David Correa 5933 NE Win Sivers Drive #205, Portland, OR 97220 United States USA/Canada (Toll Free): [phone], [phone] UK: [phone] Hong Kong: [phone] India (Pune): [phone] Fax: [phone] [email protected] Web: https://www.alliedmarketresearch.com/reports-store/life-sciences Follow Us on LinkedIn: https://www.linkedin.com/showcase/life-sciences-industry-research/

[omkarpatel]

The Internal Nasal Dilators Market Poised to Expand at a Steep Pace due to Growing Prevalence of Nasal Obstructions

Internal nasal dilators are effective in treating nasal obstructions, snoring and related breathing disorders. Internal nasal dilators are versatile medical devices placed internally inside the nose to treat nasal obstructions and snoring issues by expanding the nasal valves and improving nasal airflow and breathing. They provide a non-invasive solution for conditions like nasal septum deviation, enlarged turbinates or allergies and help open blocked nasal passages. Some key advantages include ease of use, affordability and bypassing the need for complex surgeries. Growing incidence of nasal breathing disorders worldwide owing to lifestyle changes, pollutions and allergens has increased the demand for nasal dilators in recent years. The Global Internal Nasal Dilators Market is estimated to be valued at US$ 10.11 Bn in 2024 and is expected to exhibit a CAGR of 11% over the forecast period 2023 to 2030. Key Takeaways Key players operating in the Internal Nasal Dilators market are Becton, Dickinson and Company, Gerresheimer AG, Sharps Technology, Inc., Cardinal Health, lomMedical, MHC Medical Products, LLC, Sol-Millennium, UltiMed Inc., VOGT MEDICAL, Retractable Technologies, Inc., Dmcmedical, BIOCORP, Hindustan Syringes & Medical Devices Ltd, Owen Mumford Ltd., B. Braun SE, Terumo Europe NV, Smiths Group plc, Merit Medical Systems, Nipro Corporation, GPC Medical Ltd., AdvaCare Pharma. The demand for nasal dilators is growing due to increasing awareness about products, rising cases of nasal obstructions and growing preference for non-surgical treatment options. Key players are investing in advanced technologies to develop more effective and user-friendly nasal dilator designs. Market Trends Some key trends being witnessed in the internal nasal dilators market include growing popularity of silicone nasal dilators and development of innovations like disposable dilators, sensors integrated dilators etc. Manufacturers are focusing on developing multifunctional devices that can help with other issues like dry nose in addition to nasal obstruction. Increasing adoption of digital technologies is also enabling remote monitoring of patients using dilators. Market Opportunities The market is expected to gain further impetus due to growing awareness through online channels and focus on pediatric patients suffering from nasal disorders like deviated septum. Emerging economies with large patient pools also offer significant lucrative business opportunities. Further technological advancements in material sciences can facilitate development of advanced dilators addressing limitations of existing products. Impact of COVID-19 on Internal Nasal Dilators Market growth The COVID-19 pandemic has significantly impacted the growth of the internal nasal dilators market. During the initial phases of the pandemic in 2020, various restrictions like nationwide lockdowns and supply chain disruptions adversely affected the market. Manufacturing and elective procedures using internal nasal dilators were suspended to prioritize COVID care. This led to a decline in demand and sales for these dilators globally. However, with the resumption of healthcare services and easing of lockdowns from mid-2020, the market has started recovering gradually. There is growing awareness among patients about breathing-related issues like deviated septum or nasal congestion experienced due to COVID infection. This is driving the demand for natural internal nasal dilators as a preventive measure. Manufacturers are also adjusting their supply chains and distribution channels to ensure seamless supplies. Telehealth and digital consultations have enabled continued access to healthcare during the pandemic.

#healthcare

[sanemyamen]

Medical Syringe Market Unidentified Segments – The Biggest Opportunity Of 2022

Advance Market Analytics released a new market study on Global Medical Syringe Market Research report which presents a complete assessment of the Market and contains a future trend, current growth factors, attentive opinions, facts, and industry validated market data. The research study provides estimates for Global Medical Syringe Forecast till 2027*.

A syringe is a medical device that is used to inject fluid into or withdraw fluid from, the body. A medical syringe comprises a needle attached to a hollow cylinder that is fitted with a sliding plunger. The descendent movement of the plunger injects fluid; upward movement withdraws fluid. Medical syringes were once made of metal or glass, and requisite cleaning and sterilization before they could be used again. Nowadays most syringes used in medicine are plastic and disposable.

Key Players included in the Research Coverage of Medical Syringe Market are Becton, Dickinson and Company (United States),B. Braun Melsungen AG(Germany),Gerresheimer (Germany),Hindustan Syringes & Medical Devices Limited (India),Terumo Corporation (Japan),Nipro Corporation (Japan),Schott AG (Germany),Medtronic plc (Ireland),Smiths Medical (United States),Medline (United States)

What's Trending in Market: Technological Advancements Spur Evolution in the Syringes

Growing Need for Further Advancements in Safety Syringes

Challenges: Rising Focus towards Development of Alternative Drug Delivery Methods

Opportunities: Developing Healthcare Infrastructure among the Developing Countries

Market Growth Drivers: Growing Incidence of Chronic Diseases

Increasing Trend towards Plastic Pre Filled Syringes

The Global Medical Syringe Market segments and Market Data Break Down by Type (Non-Disposable Syringes, Disposable Syringes (Safety Syringes, Conventional Syringes)), Application (Hospital, Clinic, Others), Distribution Channel (Online, Offline)

To comprehend Global Medical Syringe market dynamics in the world mainly, the worldwide Medical Syringe market is analyzed across major global regions. AMA also provides customized specific regional and country-level reports for the following areas. • North America: United States, Canada, and Mexico. • South & Central America: Argentina, Chile, Colombia and Brazil. • Middle East & Africa: Saudi Arabia, United Arab Emirates, Israel, Turkey, Egypt and South Africa. • Europe: United Kingdom, France, Italy, Germany, Spain, Belgium, Netherlands and Russia. • Asia-Pacific: India, China, Japan, South Korea, Indonesia, Malaysia, Singapore, and Australia. Presented By

AMA Research & Media LLP

[pharmaceuticals88]

Syringe Market Key Competitors, SWOT Analysis, Business opportunities, Trend Analysis 2029

The Syringe Market size At USD XX MILLION by 2029, exhibiting a CAGR of 11.4% during 2022-2029

Syringe Market Overview

The Syringe Market report is a comprehensive overview of the market, including a review of its major segments. Alliances are developed after thorough primary and secondary studies. By speaking with industry experts and collecting their data, in-depth market data is produced. The report provides a thorough account of many market factors, including trends, segmentation, growth prospects, chances, difficulties, and competitive analyses. Get a Sample copy of the report:

https://pharmaresearchconsulting.com/reports/syringe-market 

List of Key Players Of Syringe Market Report:

Becton Dickinson and Company, B. Braun Melsungen AG, Hindustan Syringes & Medical Devices Limited, Smiths Medical, Cardinal Health Inc.  

Key Segments Covered in Syringe Market

By Usage, it is segmented into

Sterilizable/Reusable Syringes

Disposable Syringes

Conventional Syringes

Safety Syringes

Prefilled Syringes

By Application, it is segmented into

Insulin Syringes

Botox

Osteoarthritis

Human Growth Hormone

Other App 

Competitive Landscape

Syringe Market are showing an increasing amount of interest in creating unique products. In addition, several companies are collaborating, merging, and acquiring one another. In the upcoming years, all of these initiatives are anticipated to drive the global Syringe Market to new heights. 

The Syringe Market Regional Analysis Covers

– North America: United States, Canada, and Mexico. – South & Central America: Argentina, Chile, and Brazil. – Middle East & Africa: Saudi Arabia, UAE, Turkey, Egypt and South Africa. – Europe: UK, France, Italy, Germany, Spain, and Russia. – Asia-Pacific: India, China, Japan, South Korea, Indonesia, Singapore, and Australia. 

Get in Touch with Us: - Phone No.+1 [phone]

Mail to: [email protected]

#Syringe Market Research Syringe Market Forecast Syringe Market Size Syringe Market Share Syringe Market Trends Syringe Market Overview

[healthinfotech]

The Diabetes care Devices Market size is estimated to Reach US$ 39,382.3 Million by 2027

The diabetes care devices market growth is attributed to the rising incidence of diabetes, growing geriatric population, increasing prevalence of obesity across the globe, and rapid technological advancement in diabetes care devices.

Diabetes is a life-threatening chronic disease with no specialized cure. It is mainly caused by the body’s inability to produce insulin. This inability prevents the body from regulating blood glucose levels. There are two types of diabetes diabetes type-I (also known as diabetes insipidus) and diabetes type-II (also termed as diabetes mellitus). Incidences and prevalence of diabetes are steadily increasing across the globe. Type 2 diabetes is the most prevalent form of diabetes and has increased due to significant cultural and societal changes. In high-income countries, up to 91% of adults have type 2 diabetes. According to International Diabetes Federation (IDF), approximately 425 million people were detected with diabetes in 2017and is expected to reach 629 million by 2045 across the globe.

Moreover, in 2017, a total of 30,187 people were diagnosed with diabetes in the US. Diabetes is one of the chronic disorders which require sustained care throughout. Thus, the increasing prevalence of diabetes is expected to boost the diabetes care market size during the forecast period.

Insulin is delivered into the body using needles, insulin pens, and insulin pumps. Insulin pumps are small, computerized diabetes management devices connected with a cannula under the skin that is used to deliver a slow continuous level of insulin. The flow can be controlled by an individual depending on the requirement. The optimal diabetes management depends on accurate glucose monitoring devices. The increasing advancements in blood glucose (BG) monitoring technology have resulted in improved accuracy, smaller required blood volumes, and the ability to transfer data between the BG meter and insulin delivery devices.

Pen needles and syringes are the most commonly used devices for injecting insulin into diabetic patients. Various manufacturers are developing innovative products to sustain in the highly fragmented global pen needles market. The easy regulatory approvals in Asian countries have led to mid-sized companies entering the diabetes care devices market and competing with the local and established players. For instance, in May 2018, Hindustan Syringes and Medical Devices (HMD), one of the leading manufacturers of disposable syringes, introduced “Dispovan” insulin pen needle the first made-in-India disposable pen needle that is more technologically efficient and affordable than that of the currently available products in the market. The development of pen needles with precise lubrication to reduce pain sensation has been another focus of manufacturers during the research.Thus, the ongoing technological advancements are expected to assist the diabetes care devices market size over the forecast period.

The global diabetes care devices market, based on product, is bifurcated into glucose monitoring devices and insulin delivery devices. The glucose monitoring devices segment is further subsegmented into glucometers, lancets, testing strips, and other glucose monitoring devices. The insulin delivery devices segment is further categorized into insulin pens, insulin syringe, insulin pumps, and other insulin delivery devices. The global diabetes care devices market, based on end user, is segmented into homecare and hospitals & clinics.

Apart from the developments for the diabetes care devices market, the key market players are developing innovative products that assists in the diagnosis and monitoring of the diabetic conditions. For instance, the current Accu-Chek portfolio of F. Hoffmann-La Roche Ltd. offers people with diabetes and healthcare professional’s innovative products and impactful solutions for convenient, efficient and effective diabetes management. Similarly, the companies are performing inorganic growth market for instance, in February, 2017, Roche and Medtronic entered into an agreement to develop a next-gen BG meter that will intertwine Accu-Chek glucose monitoring technology into a future Medtronic pump system.

#diabetes #diabetic #glucose monitoring #insuline

[ewnsnews]

Hindustan Syringes gets government order for more syringes for COVID jabs

Hindustan Syringes gets government order for more syringes for COVID jabs

Image Source : HMDHEALTHCARE.COM Hindustan Syringes gets govt order for more syringes for COVID jabs.   Medical syringe major Hindustan Syringes and Medical Devices Ltd (HMD) has received an order for supply of 132.5 million syringes from the Centre, a top company official said on Friday. The company is not accepting any export orders and has diverted the supply of 100 million pieces from an…

View On WordPress

#corona vaccination #coronavirus pandemic #COVID jabs #covid strain #Government order #Hindustan Syringes #Hindustan Syringes latest news updates #Hindustan Syringes news #Hindustan Syringes news breaking #latest national news updates #syringes

[newsbunddle]

The world needs syringes. This Indian company jumped in to make 5,900/minute

The world needs syringes. This Indian company jumped in to make 5,900/minute

Written by Karan Deep Singh In late November, an urgent email popped up in the inbox of Hindustan Syringes & Medical Devices, one of the world’s largest syringe makers. It was from UNICEF, the United Nations agency for children, and it was desperately seeking syringes. Not just any would do. These syringes must be smaller than usual. They had to break if used a second time, to prevent spreading…

View On WordPress

#global syringe shortage #hindustan syringes #indian express #syringes

[5545321]

Pen Needles Market to be Worth $12.88 Billion by 2031

Meticulous Research®—a leading global market research company, published a research report titled ‘Pen Needles Market by Type (Standard, Safety), Needle Length, Usability (Disposable, Reuse), Application (Insulin, Growth Hormone, GLP-1), Distribution Channel (Hospital Pharmacy, Retail, Online), Setting (Home Care, Hospital) — Global Forecast to 2031.’

According to this latest publication from Meticulous Research®, the pen needles market is projected to reach $12.88 billion by 2031, at a CAGR of 9.9% during the forecast period. The growth of this market is driven by factors such as the rising prevalence of diabetes, growing demand for self-administration of drugs, advancements in technology, and rising healthcare expenditure. Moreover, the preference for pen needles over vials and syringes, favorable reimbursement policies, and emerging economies are expected to offer significant market growth opportunities.

However, concerns regarding needlestick injuries restrain the market’s growth. Additionally, the reuse of pen needles, limited access to healthcare in developing nations, and lack of awareness about proper usage of pen needles pose challenges to the market’s growth.

Key Players

The key players operating in the pen needles market are Becton, Dickinson and Company (U.S.), Novo Nordisk A/S (Denmark), Ypsomed AG (Switzerland), Owen Mumford Limited (U.K.), B. Braun Melsungen AG (Germany), Terumo Group (Japan), Allison Medical, Inc. (U.S.), Cardinal Health, Inc. (U.S.), UltiMed, Inc. (U.S.), Hindustan Syringes & Medical Devices Ltd (India), and Nanchang YiLi Medical Instrument Co.,LTD (China).

Pen Needles Market: Future Outlook

The pen needles market is segmented based on Type (Standard Pen Needles, Safety Pen Needles), Needle Length (4 mm, 5 mm, 6 mm, 8 mm, 10 mm, 12 mm & Above), Usability (Single Use/Disposable, Reusable), Application (Insulin Therapy, Growth Hormone Therapy, GLP-1 Therapy, Other Applications), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), Healthcare Setting (Home Care, Hospitals & Clinics, and Other Healthcare Settings), and Geography. The study also evaluates industry competitors and analyzes the regional and country-level markets.

Based on type, the pen needles market is segmented into standard pen needles and safety pen needles. In 2024, the safety pen needles segment is expected to account for the larger share of the pen needles market. The large market share of this segment can be attributed to the advantages provided by safety pen needles, including reduced risk of needlestick injuries, assured delivery of the full medication dose in a safe manner, and enhanced control during the injection process with clear visibility of the sterile needle. Additionally, the incorporation of safety shields in safety pen needles further contributes to the segment's significant market share.

Based on needle length, the pen needles market is segmented into 4 mm, 5 mm, 6 mm, 8 mm, 10 mm, 12 mm & above. In 2024, the 4 mm segment is expected to account for the largest share of the pen needles market. The large market share of this segment can be attributed to the advantages offered by 4 mm needles, such as minimal pain and discomfort during insulin injections. Furthermore, companies in the pen needles market are focusing on improving their product portfolios through the introduction of innovative offerings. For instance, in September 2022, Terumo Group (Japan) launched FineGlide, a sterile pen needle designed for patients requiring insulin injections or other forms of self-medication.

Based on usability, the pen needles market is segmented into single-use/disposable and reusable. In 2024, the single-use/disposable segment is expected to account for the larger share of the pen needles market. The large market share of this segment can be attributed to technological advancements in insulin delivery devices and growing awareness regarding hygiene and needlestick injuries.

Based on application, the pen needles market is segmented into insulin therapy, growth hormone therapy, GLP-1 therapy, and other applications. In 2024, the insulin therapy segment is expected to account for the largest share of the pen needles market. The large market share of this segment can be attributed to the rising demand and awareness of insulin therapy, driven by the high prevalence of diabetes. For instance, according to the International Diabetes Federation, the global diabetic population reached 537 million in 2021. Projections indicate an increase to 643 million by 2030 and 783 million by 2045.

Based on distribution channel, the pen needles market is segmented into hospital pharmacies, retail pharmacies, and online channels. In 2024, the retail pharmacies segment is expected to account for the largest share of the pen needles market. The large market share of this segment can be attributed to the advantages provided by retail pharmacies compared to other distribution channels. Retail pharmacies offer patients the convenience of accessing pen needles without the need for a prescription, thereby simplifying diabetes management for individuals.

Based on healthcare setting, the pen needles market is segmented into home care, hospitals and clinics, and other healthcare settings. In 2024, the home care segment is expected to account for the largest share of the pen needles market. The large market share of this segment can be attributed to the growing awareness of diabetes management and the rising number of diabetes cases. Additionally, the adoption of pen needles in home care settings enables individuals to manage their healthcare independently. By self-administering medications, individuals gain greater control over their treatment, seamlessly integrating it into their daily routines. This autonomy often leads to improved medication adherence and better overall health outcomes.

Geographic Review

This research report analyzes major geographies and provides a comprehensive analysis of North America (U.S. and Canada), Europe (Germany, France, U.K., Italy, Spain, Austria, Netherlands, and Rest of Europe), Asia-Pacific (China, Japan, India, South Africa, Australia, and Rest of Asia-Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and the Middle East & Africa. In 2023, North America is expected to account for the largest share of the pen needles market, followed by Europe and Asia-Pacific. Furthermore, in 2023, the U.S. is expected to be the largest market shareholder in North America. North America’s major market share is attributed to the highly developed healthcare infrastructure and the presence of major market players such as Becton, Dickinson and Company (U.S.), and Cardinal Health, Inc. (U.S.).

Download Sample Report Here @ https://www.meticulousresearch.com/download-sample-report/cp_id=5796

Key questions answered in the report:

Which are the high-growth market segments in terms of type, needle length, usability, application, distribution channel, healthcare setting, and region/country?

What was the historical market size for pen needles across the globe?

What are the market forecasts and estimates for 2024–2031?

What are the major drivers, restraints, and opportunities in the global pen needles market?

Who are the major players in the global pen needles market?

What is the competitive landscape like, and who are the market leaders in the global pen needles market?

What are the recent developments in the pen needles market?

What strategies are adopted by the major players in the pen needles market?

What are the geographical trends and high-growth regions/countries?

Contact Us: Meticulous Research® Email- [email protected] Contact Sales- [phone] Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research

#Pen Needles Market

[sapphire-sv]

The World Needs More Syringes - See How this Indian Man Makes 5,900 Syringes per minute

The World Needs More Syringes – See How this Indian Man Makes 5,900 Syringes per minute

In late November, an urgent email popped up in the inbox of Hindustan Syringes & Medical Devices, one of the world’s largest syringe makers. It was from UNICEF, the United Nations agency for children, and it was desperately seeking syringes. Not just any would do. These syringes must be smaller than usual. They had to break if used a second time, to prevent spreading disease through accidental…

View On WordPress

#Covid-19 #Hindustan Syringes & Medical Devices Ltd #needs #Rajiv Nath #Syringes #World

[ken-research-market-research]

India Medical Consumables Market Research Report And Market Outlook: Ken Research How the India Medical Consumables Market is Positioned? The medical consumables market in India is currently at its growth stage with rise in number of domestic and foreign players.

#3M Medical Consumable India Market Revenue #B Braun Medical Consumable India Market Size #Becton Dickinson Medical Consumable India Market Shares #Bsn Medical Consumable India Market Revenue #Centennial Surgical Medical Consumable India Market Shares #Coloplast Medical Consumable India Market Size #Convatech Medical Consumable India Market Size #Datt Mediproducts Medical Consumable India Market Shares #East India Medical Consumables Market #Fresenius Medical Consumable India Market Shares #Global Medikit Medical Consumable India Market Revenue #Hemant Surgical Medical Consumable India Market Revenue #Hindustan Syringes India Consumables Market Revenue #Hollister Medical Consumable India Market Shares #India Absorbable Sutures Market #India Advanced Silver Dressings Market #India Alginate Market #India Blood Bag Market #India Cardiovascular Catheter Market #India Catgut Absorbable Sutures Market #India Catheters Market Analysis #India Clinics Medical Consumables Market #India Collagen Market #India Compression Bandage And Plasters Market #India Dispensaries Medical Consumables Market #India Disposables Blood Bags Market Growth #India Double Blood Bags Market #India Dressing Market Analysis #India Endotracheal Tubes Market #India Epidural Catheter Market

[newsresults]

India's biggest syringe maker boosts production to meet virus vaccine demand

India’s biggest syringe maker boosts production to meet virus vaccine demand

[ad_1]

India’s biggest syringe manufacturer is ramping up production to churn out a billion units, anticipating a surge in demand as the global race to find a coronavirus vaccine heats up.

While the focus on tackling the pandemic has mostly been on the development of vaccines, experts say medical essentials to administer them are also vital.

Hindustan Syringes — one of the world’s largest…

View On WordPress

#coronavirus #coronavirus vaccine #COVID-19 #covid-19 vaccine #Hindustan Syringes

[insightslicelive]

Disposable Syringes Market Research Report 2021-2032 | Featuring Key Players: Simplist (Fresenius Kabi AG), Terumo Corp, Hindustan Syringes & Medical Devices Ltd

Disposable Syringes Market Research Report 2021-2032 | Featuring Key Players: Simplist (Fresenius Kabi AG), Terumo Corp, Hindustan Syringes & Medical Devices Ltd

insightSLICE has published a report based on the latest changes in the Global Disposable Syringes Market During the forecast era, the study provides a detailed overview of the most profitable opportunities around the different segments in terms of revenues and volumes. With an emphasis on important aspects such as drivers, barriers, opportunities, and competitive environment evaluation, the study…

View On WordPress

#Disposable Syringes #Disposable Syringes industry #Disposable Syringes market #Disposable Syringes market share #Disposable Syringes market size #Disposable Syringes maufacturers growth analysis

[myabhijitr]

Syringes Market 2022: Size, Share, Future Development, Industry Outlook, Growth Analysis by 2028 | Treumo Corporation, Medtronic, Becton, Dickinson and Company, B. Braun Medical

Overview

Syringes are used to inject medicine into patients. A syringe is a hollow tube with a needle that pierces the skin. The plunger is used to control the amount of medicine injected. It is often fitted with a hypodermic needle. A syringe has an open end that is often fitted with a nozzle or tubing. Syringes are often used to administer injections, infuse intravenous therapy, apply compounds, and draw/measure liquids. Most syringes come with graduated markings that allow users to easily measure the volume of fluid. Syringes’ openings are standardized, so it is important to check the mL and cc markings to ensure the correct quantity of fluid. The cc numbers on the side of the barrel are the most important parts of a syringe, because they determine the accuracy of the measurement.

Get PDF Sample Copy (Including Full TOC, List of Tables & Figures, Chart) @ https://www.coherentmarketinsights.com/insight/request-sample/917

Competitive Landscape

Major companies contributing to the global syringes market include Hindustan Syringes and Medical Devices Limited, B. Braun Medical Inc., Hamilton, Becton, Dickinson and Company, Treumo Corporation, Medtronic Plc., Codan Medizinische Gerate GmbH & Co KG., Gerresheimer AG, SCHOTT AG, Smiths Medical, and NIPRO Corporation.

Drivers

A boom in the number of hospital admissions amidst the growing prevalence of chronic diseases is expected to augment growth of the syringes market throughout the forecast period.

In addition to this, the growing prominence of vaccines and the increasing number of immunization programs due to the prevalence of infectious diseases is expected to supplement growth of the syringes market during the forecast period.

Summary of the COVID-19 Aftermath

The global syringes market has responded positively to the prevalence of the COVID-19 pandemic. Syringes were widely used in critical COVID patients as they were found to mitigate the virus transmission due to their one-time use. With the emergence of new C-19 variants, the market seems to have a long road ahead for expansion.

Request PDF Brochure with Latest Insights @ https://www.coherentmarketinsights.com/insight/request-pdf/917

Key Takeaways

The syringes market is anticipated to grow at a CAGR of 10.3% during the forecast period owing to the increasing prevalence of infectious diseases and increasing government support. For instance, in December 2021, Hindustan Syringes and Medical Devices received permission to produce syringes in the National Capital of Delhi, India, to boost C-19 vaccination drives.

On the geographical front, the North American region is a treasure island for the global syringes market in view of growing demand from the healthcare sector and the initiation of seasonal immunization programs every year to combat influenza infections.

On a related note, Asia Pacific is another region of interest for the global syringes market on account of a high COVID-19 caseload and growing demand for injectable drugs.

[healthinfotech]

Diabetes Care Devices :  BD; Novo Nordisk A/S; B. Braun Melsungen AG; Insulet Corporation; Tandem Diabetes Care, key Companies in Smart Diabetes Devices

The diabetes care devices market size is estimated to reach US$ 39,382.3 million by 2027 from US$ 23,354.3 million in 2018; it is expected to grow at a CAGR of 6.1% during 2019-2027.

The diabetes care devices market growth is attributed to the rising incidence of diabetes, growing geriatric population, increasing prevalence of obesity across the globe, and rapid technological advancement in diabetes care devices.

Diabetes is a life-threatening chronic disease with no specialized cure. It is mainly caused by the body’s inability to produce insulin. This inability prevents the body from regulating blood glucose levels. There are two types of diabetes diabetes type-I (also known as diabetes insipidus) and diabetes type-II (also termed as diabetes mellitus). Incidences and prevalence of diabetes are steadily increasing across the globe. Type 2 diabetes is the most prevalent form of diabetes and has increased due to significant cultural and societal changes. In high-income countries, up to 91% of adults have type 2 diabetes. According to International Diabetes Federation (IDF), approximately 425 million people were detected with diabetes in 2017and is expected to reach 629 million by 2045 across the globe.

Moreover, in 2017, a total of 30,187 people were diagnosed with diabetes in the US. Diabetes is one of the chronic disorders which require sustained care throughout. Thus, the increasing prevalence of diabetes is expected to boost the diabetes care market size during the forecast period.

Insulin is delivered into the body using needles, insulin pens, and insulin pumps. Insulin pumps are small, computerized diabetes management devices connected with a cannula under the skin that is used to deliver a slow continuous level of insulin. The flow can be controlled by an individual depending on the requirement. The optimal diabetes management depends on accurate glucose monitoring devices. The increasing advancements in blood glucose (BG) monitoring technology have resulted in improved accuracy, smaller required blood volumes, and the ability to transfer data between the BG meter and insulin delivery devices.

Pen needles and syringes are the most commonly used devices for injecting insulin into diabetic patients. Various manufacturers are developing innovative products to sustain in the highly fragmented global pen needles market. The easy regulatory approvals in Asian countries have led to mid-sized companies entering the diabetes care devices market and competing with the local and established players. For instance, in May 2018, Hindustan Syringes and Medical Devices (HMD), one of the leading manufacturers of disposable syringes, introduced “Dispovan” insulin pen needle the first made-in-India disposable pen needle that is more technologically efficient and affordable than that of the currently available products in the market. The development of pen needles with precise lubrication to reduce pain sensation has been another focus of manufacturers during the research.Thus, the ongoing technological advancements are expected to assist the diabetes care devices market size over the forecast period.

The global diabetes care devices market, based on product, is bifurcated into glucose monitoring devices and insulin delivery devices. The glucose monitoring devices segment is further subsegmented into glucometers, lancets, testing strips, and other glucose monitoring devices. The insulin delivery devices segment is further categorized into insulin pens, insulin syringe, insulin pumps, and other insulin delivery devices. The global diabetes care devices market, based on end user, is segmented into homecare and hospitals & clinics.

Apart from the developments for the diabetes care devices market, the key market players are developing innovative products that assists in the diagnosis and monitoring of the diabetic conditions. For instance, the current Accu-Chek portfolio of F. Hoffmann-La Roche Ltd. offers people with diabetes and healthcare professional’s innovative products and impactful solutions for convenient, efficient and effective diabetes management. Similarly, the companies are performing inorganic growth market for instance, in February, 2017, Roche and Medtronic entered into an agreement to develop a next-gen BG meter that will intertwine Accu-Chek glucose monitoring technology into a future Medtronic pump system.

#diabetes